世界のバイオテクノロジー・製薬サービス向けアウトソーシング市場規模は、2028年までに994億米ドルに達する見込みです。2021年から2028年までのCAGRは5.8%で拡大すると予想されています。低分子化合物に加えて生物製剤の需要が高まっていることから、バイオテクノロジーや医薬品製造のための委託製造機関（CMO）/委託研究機関（CRO）のサービスポートフォリオが拡大しています。小規模な製薬/バイオテクノロジー企業は、自社で開発、製造、薬事、製品メンテナンス、製品設計・開発、製品テスト・バリデーション、トレーニング・教育を行う際に、実質的な専門知識や高価な能力が不足しているといった課題に直面しています。これにより、CMOやCROの成長に有利な機会が生まれています。受託サービスは成長しており、戦略的で、的を絞り、計画的になっています。これらの要因は、市場全体におけるCMO/CROのシェア拡大に極めて重要な役割を果たすと考えられます。
価格圧力の高まり、規制上の課題、および特許の満了により、バイオテクノロジーおよび製薬業界の利益率は低下しています。 契約サービスは、これらの問題を克服するのに役立つため、企業間で「戦略的競争力のある武器」と見なされます。
持続可能なサプライヤーを選択することは、長期的にはコスト削減につながるため、これらのサービスはお客様にコスト削減を提供します。また、生産施設や研究施設の運営・管理にかかる時間の短縮にもつながります。研究・製造受託は、低コストでの製品開発・製造を可能にします。
さらに、アウトソーシングサービスは、貿易障壁を克服し、企業の海外市場への参入を促進するのに役立ちます。 これらの利点のために、いくつかの企業は、生産設備に資本を投資して熟練労働者を雇うのではなく、サービスをアウトソーシングすることを選択します。
コロナウイルスの発生は、バイオテクノロジーや製薬会社のサードパーティサービスプロバイダや臨床試験に大きな影響を与えており、試験の遅延、中断、終了などの事態を引き起こしています。この世界的な危機により、バーチャル臨床試験必要性が強調され、テクノロジーやソフトウェア・ソリューションを活用することが求められています。機械学習ベースのプラットフォーム、人工知能、医薬品製造の自動化、革新的な試験デザインの採用が増えると、今後数年間でCROとCMOの展望が変わると予測されています。 再生医療などの斬新で革新的な治療法へのバイオ医薬品および医薬品への投資は、医薬品開発サービスとともに研究開発活動を推進しています。
近年、生物製剤業界は大幅に成長し、ナノボディ、rDNA、合成ワクチン、融合タンパク質、可溶性受容体、免疫複合体、免疫治療薬などの新しいタイプの製品が登場しています。生物製剤による疾病治療の革新により、この分野は生物製剤と定義済みの化学物質を組み合わせたハイブリッド構造を探求する多くの機会を提供しています。生物製剤の著しい成長により、生物製剤の開発・製造のアウトソーシングの需要が高まると予想されます。
目次
Table of Contents
Chapter 1 Methodology and Scope
1.1 Market Segmentation & Scope
1.1.1 Service
1.1.2 End Use
1.1.3 Regional Scope
1.1.4 Estimates And Forecast Timeline
1.2 Research Methodology
1.3 Information Procurement
1.3.1 Purchased Database
1.3.2 GVR’sInternal Database
1.3.3 Secondary Sources
1.3.4 Primary Research
1.3.5 Details Of Primary Research
1.3.5.1 Data For Primary Interviews In North America
1.3.5.2 Data For Primary Interviews In Europe
1.3.5.3 Data For Primary Interviews In Asia Pacific
1.3.5.4 Data For Primary Interviews In Latin America
1.3.5.5 Data For Primary Interviews In MEA
1.4 Information or Data Analysis
1.4.1 Data Analysis Models
1.5 Market Formulation & Validation
1.6 Model Details
1.6.1 Commodity Flow Analysis (Model 1)
1.7 List of Secondary Sources
1.8 List of Primary Sources
1.9 List of Abbreviations
1.10 Objectives
1.10.1 OBJECTIVE - 1:
1.10.2 OBJECTIVE - 2:
1.10.3 OBJECTIVE - 3:
1.10.4 OBJECTIVE - 4:
Chapter 2. Executive Summary
2.1 Market Outlook
Chapter 3. Biotechnology & Pharmaceutical Services Outsourcing Market: Variables, Trends, & Scope
3.1 Market Segmentation and Scope
3.2 Market Driver Analysis
3.2.1 Increasing outsourcing of R&D activities
3.2.2 Changing regulatory landscape
3.2.3 Increasing focus on core competencies by pharmaceutical and biotechnology companies
3.2.4 Growing drug development costs coupled with high clinical development failure rates
3.2.5 Increasing mergers and collaborations
3.3 Market Restraint Analysis
3.3.1 Monitoring issues and lack of standardization
3.3.2 Loss of control
3.3.3 Data security issues
3.4 Penetration & Growth Prospect Mapping
3.5 Porter’s Five Forces Analysis
3.6 PESTEL Analysis
3.7 End-use Perception Analysis
3.7.1 Why do you outsource biotechnology & pharmaceutical services to CROs?
3.7.2 Percentage of outsourcing of different services.
3.7.3 Importance of CRO selection parameters (Ranking from 1 to 5, where 1 - least important and 5 - most important).
3.8 Service Price Analysis
3.8.1 Pricing strategy
3.8.1.1 Transactional business models
3.8.1.2 Performance-based business models
3.8.1.3 Outcome-based business models
3.8.2 Consulting rates
3.8.3 Heat map for pricing analysis
3.9 Covid Impact on Biotechnology Industry
3.9.1 Covid-19 Impact on Clinical Trials
3.9.2 Disrupted clinical trials
3.9.3 Obstacles in clinical trials
Chapter 4. Biotechnology & Pharmaceutical Services Outsourcing Market: Service Segment Analysis
4.1 Biotechnology & Pharmaceutical Services Outsourcing: Market Share Analysis, 2020 & 2028
4.2 Consulting
4.2.1 Consulting Market, 2016 - 2028 (USD Million)
4.2.2 Regulatory compliance
4.2.2.1 Regulatory compliance market, 2016 - 2028 (USD Million)
4.2.3 Remediation
4.2.3.1 Remediation market, 2016 - 2028 (USD Million)
4.2.4 Quality management systems consulting
4.2.4.1 Quality management systems consulting market, 2016 - 2028 (USD Million)
4.2.5 Others
4.2.5.1 Others market, 2016 - 2028 (USD Million)
4.3 Auditing and assessment
4.3.1 Auditing and assessment Market, 2016 - 2028 (USD Million)
4.4 Regulatory affairs
4.4.1 Regulatory affairs Market, 2016 - 2028 (USD Million)
4.4.2 Clinical trial applications & product registration
4.4.2.1 Clinical trial applications & product registration market, 2016 - 2028 (USD Million)
4.4.3 Regulatory writing & publishing
4.4.3.1 Regulatory writing & publishing market, 2016 - 2028 (USD Million)
4.4.4 Legal representation
4.4.4.1 Legal representation market, 2016 - 2028 (USD Million)
4.4.5 Others
4.4.5.1 Others market, 2016 - 2028 (USD Million)
4.5 Product Maintenance
4.5.1 Product maintenance Market, 2016 - 2028 (USD Million)
4.6 Product Design & Development
4.6.1 Product Design & Development Market, 2016 - 2028 (USD Million)
4.7 Product Testing & Validation
4.7.1 Product Testing & Validation Market, 2016 - 2028 (USD Million)
4.8 Training & Education
4.8.1 Training & Education Market, 2016 - 2028 (USD Million)
4.9 Others
4.9.1 Others Market, 2016 - 2028 (USD Million)
Chapter 5. Biotechnology & Pharmaceutical Services Outsourcing Market: End-use Segment Analysis
5.1Biotechnology & Pharmaceutical Services Outsourcing: Market Share Analysis, 2020 & 2028
5.2 Pharmaceutical Companies
5.2.1 Pharmaceutical Companies market, 2016 - 2028 (USD Million)
5.3 Biotech Companies
5.3.1 Biotech Companies market, 2016 - 2028 (USD Million)
Chapter 6. Biotechnology & Pharmaceutical Services Outsourcing Market: Regional Analysis
6.1Biotechnology & Pharmaceutical Services Outsourcing: Market Share Analysis, 2020 & 2028
6.2 North America
6.2.1 North America Biotechnology & Pharmaceutical Services Outsourcing Market, 2016 - 2028 (USD Million)
6.2.2 U.S.
6.2.2.1 U.S. biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.2.3 Canada
6.2.3.1 Canada biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.3 Europe
6.3.1 Europe Biotechnology & Pharmaceutical Services Outsourcing Market, 2016 - 2028 (USD Million)
6.3.2 U.K.
6.3.2.1 U.K. biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.3.3 Germany
6.3.3.1 Germany biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.3.4 France
6.3.4.1 France biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.3.5 Italy
6.3.5.1 Italy biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.3.6 Spain
6.3.6.1 Spain biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.4 Asia Pacific
6.4.1 Asia Pacific Biotechnology & Pharmaceutical Services Outsourcing Market, 2016 - 2028 (USD Million)
6.4.2 Japan
6.4.2.1 Japan biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.4.3 China
6.4.3.1 China biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.4.4 India
6.4.4.1 India biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.4.5 Australia
6.4.5.1 Australia biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.4.6 South Korea
6.4.6.1 South Korea biotechnology & pharmaceutical services outsourcing Market, 2016 - 2028 (USD Million)
6.5 Latin America
6.5.1 Latin America Biotechnology & Pharmaceutical Services Outsourcing Market, 2016 - 2028 (USD Million)
6.5.2 Brazil
6.5.2.1 Brazil biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.5.3 Mexico
6.5.3.1 Mexico biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.5.4 Argentina
6.5.4.1 Argentina biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.6 MEA
6.6.1 MEA Biotechnology & Pharmaceutical Services Outsourcing Market, 2016 - 2028 (USD Million)
6.6.2 South Africa
6.6.2.1 South Africa biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.6.3 Saudi Arabia
6.6.3.1 Saudi Arabia biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
6.6.4 UAE
6.6.4.1 UAE biotechnology & pharmaceutical services outsourcing market, 2016 - 2028 (USD Million)
Chapter 7. Competitive Landscape
7.1 Strategy Framework
7.2 Company Profiles
7.2.1 The Quantic Group
7.2.1.1 Company overview
7.2.1.2 Service benchmarking
7.3.1 IQVIA HOLDINGS, INC.
7.3.1.1 Company overview
7.3.1.2 Financial performance
7.3.1.3 Service benchmarking
7.3.1.4 Strategic initiatives
7.4.1 Parexel International Corporation
7.4.1.1 Company overview
7.4.1.2 Financial performance
7.4.1.3 Service benchmarking
7.4.1.4 Strategic initiatives
7.5.1 Lachman Consultant Services
7.5.1.1 Company overview
7.5.1.2 Service benchmarking
7.6.1 GMP Pharmaceuticals
7.6.1.1 Company overview
7.6.1.2 Service benchmarking
7.6.1.3 Strategic initiatives
7.7.1 Concept Heidelberg GmbH
7.7.1.1 Company overview
7.7.1.2 Service benchmarking
7.8.1 Covance, INC.
7.8.1.1 Company overview
7.8.1.2 Financial performance
7.8.1.3 Service benchmarking
7.9.1 Charles River
7.9.1.1 Company overview
7.9.1.2 Financial performance
7.9.1.3 Service benchmarking
7.9.1.4 Strategic initiatives
7.10.1 PRA Health Sciences
7.10.1.1 Company overview
7.10.1.2 Financial performance
7.10.1.3 Service benchmarking
7.10.1.4 Strategic initiatives
7.11.1 ICON plc
7.11.1.1 Company overview
7.11.1.2 Financial performance
7.11.1.3 Service benchmarking
7.11.1.4 Strategic initiatives
List of Tables
Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Global Biotechnology & Pharmaceutical Service Outsourcing Market, by Region, 2016 - 2028 (USD Million)
Table 4 Global Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 5 Global Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 6 North America Biotechnology & Pharmaceutical Service Outsourcing Market, by Country, 2016 - 2028 (USD Million)
Table 7 North America Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 8 America Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 9 U.S. Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 10 U.S. Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 11 Canada Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 12 Canada Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 13 Europe Biotechnology & Pharmaceutical Service Outsourcing Market, by Country, 2016 - 2028 (USD Million)
Table 14 Europe Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 15 Europe Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 16 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 17 U.K. Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 18 Germany Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 19 Germany Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 20 France Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 21 France Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 22 Italy Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 23 Italy Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 24 Spain Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 25 Spain Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 26 Asia Pacific Biotechnology & Pharmaceutical Service Outsourcing Market, by Country, 2016 - 2028 (USD Million)
Table 27 Asia Pacific Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 28 Asia Pacific Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 29 Japan Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 30 Japan Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 31 China Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 32 China Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 33 India Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 34 India Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 35 Australia Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 36 Australia Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 37 South Korea Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 38 South Korea Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 39 Latin America Biotechnology & Pharmaceutical Service Outsourcing Market, by Country, 2016 - 2028 (USD Million)
Table 40 Latin America Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 41 Latin America Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 42 Brazil Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 43 Brazil Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 44 Mexico Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 45 Mexico Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 46 Argentina Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 47 Argentina Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 48 MEA Biotechnology & Pharmaceutical Service Outsourcing Market, by Country, 2016 - 2028 (USD Million)
Table 49 MEA Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 50 South Africa Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 51 South Africa Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 52 Saudi Arabia Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 53 Saudi Arabia Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
Table 54 UAE Biotechnology & Pharmaceutical Service Outsourcing Market, by Service, 2016 - 2028 (USD Million)
Table 55 UAE Biotechnology & Pharmaceutical Service Outsourcing Market, by End Use, 2016 - 2028 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Primary interviews in North America
Fig. 5 Primary interviews in Europe
Fig. 6 Primary interviews in Asia Pacific
Fig. 7 Primary interviews in Latin America
Fig. 8 Primary interviews in MEA
Fig. 9 Market research approaches
Fig. 10 QFD modeling for market share assessment
Fig. 11 Market formulation & validation
Fig. 12 Commodity flow analysis
Fig. 13 Biotechnology/pharmaceutical services outsourcing market snapshot (2020)
Fig. 14 Market trends and outlook
Fig. 15 Biotechnology/pharmaceutical services outsourcing market segmentation
Fig. 16 Market driver relevance analysis (Current & future impact)
Fig. 17 Pharmaceutical R&D spending, 2015 - 2024 (USD billion)
Fig. 18 Average cost per new drug development, 2000 - 2011 (USD Million)
Fig. 19 Failure rates in phase transitions during drug development
Fig. 20 Market restraint relevance analysis (Current & future impact)
Fig. 21 Penetration & growth prospect mapping
Fig. 22 Porter’s five forces analysis
Fig. 23 SWOT analysis, by factor (political & legal, economic and technological)
Fig. 24 Reasons behind outsourcing
Fig. 25 Percentage of outsourcing of different functions
Fig. 26 Selection parameters
Fig. 27 Heat map for pricing models opted by competitors
Fig. 28 Companies with affected trials, by size
Fig. 29 Affected trials, by study phase
Fig. 30 COVID-19 trials, 2020
Fig. 31 Biotechnology/pharmaceutical services outsourcing market stage outlook: Segment dashboard
Fig. 32 Biotechnology/pharmaceutical services outsourcing market: Service movement analysis
Fig. 33 Consulting market, 2016 - 2028 (USD Million)
Fig. 34 Regulatory compliance market, 2016 - 2028 (USD Million)
Fig. 35 Remediation market, 2016 - 2028 (USD Million)
Fig. 36 Quality management systems consulting market, 2016 - 2028 (USD Million)
Fig. 37 Others market, 2016 - 2028 (USD Million)
Fig. 38 Auditing and assessment market, 2016 - 2028 (USD Million)
Fig. 39 Regulatory affairs market, 2016 - 2028 (USD Million)
Fig. 40 Clinical trial applications & product registration market, 2016 - 2028 (USD Million)
Fig. 41 Regulatory writing & publishing market, 2016 - 2028 (USD Million)
Fig. 42 Legal representation market, 2016 - 2028 (USD Million)
Fig. 43 Others market, 2016 - 2028 (USD Million)
Fig. 44 Product maintenance market, 2016 - 2028 (USD Million)
Fig. 45 Product design & development market, 2016 - 2028 (USD Million)
Fig. 46 Product testing & validation market, 2016 - 2028 (USD Million)
Fig. 47 Training & education market, 2016 - 2028 (USD Million)
Fig. 48 Others market, 2016 - 2028 (USD Million)
Fig. 49 Biotechnology/pharmaceutical services outsourcing market end-use outlook: Segment dashboard
Fig. 50 Biotechnology/pharmaceutical services outsourcing market: End-use movement analysis
Fig. 51 Pharmaceutical companies market, 2016 - 2028 (USD Million)
Fig. 52 Biotech companies market, 2016 - 2028 (USD Million)
Fig. 53 Regional market: Key takeaways
Fig. 54 Regional outlook, 2020 & 2028
Fig. 55 North America market, 2016 - 2028 (USD Million)
Fig. 56 U.S. market, 2016 - 2028 (USD Million)
Fig. 57 Canada market, 2016 - 2028 (USD Million)
Fig. 58 Europe market, 2016 - 2028 (USD Million)
Fig. 59 U.K. market, 2016 - 2028 (USD Million)
Fig. 60 Germany market, 2016 - 2028 (USD Million)
Fig. 61 France market, 2016 - 2028 (USD Million)
Fig. 62 Italy market, 2016 - 2028 (USD Million)
Fig. 63 Spain market, 2016 - 2028 (USD Million)
Fig. 64 Asia Pacific market, 2016 - 2028 (USD Million)
Fig. 65 Japan market, 2016 - 2028 (USD Million)
Fig. 66 China market, 2016 - 2028 (USD Million)
Fig. 67 India market, 2016 - 2028 (USD Million)
Fig. 68 Australia market, 2016 - 2028 (USD Million)
Fig. 69 South Korea market, 2016 - 2028 (USD Million)
Fig. 70 Latin America market, 2016 - 2028 (USD Million)
Fig. 71 Brazil market, 2016 - 2028 (USD Million)
Fig. 72 Mexico market, 2016 - 2028 (USD Million)
Fig. 73 Argentina market, 2016 - 2028 (USD Million)
Fig. 74 MEA market, 2016 - 2028 (USD Million)
Fig. 75 South Africa market, 2016 - 2028 (USD Million)
Fig. 76 Saudi Arabia market, 2016 - 2028 (USD Million)
Fig. 77 UAE market, 2016 - 2028 (USD Million)
Fig. 78 Strategic Map
